Assembly Biosciences (NASDAQ:ASMB) was given a new $40.00 price target on by analysts at Mizuho.
Assembly Biosciences GAAP EPS of -$0.72 beats by $0.06, revenue of $10.79M beats by $1.47M [Seeking Alpha]
Assembly Biosciences Reports Third Quarter 2025 Financial Results and Recent Updates [Yahoo! Finance]
Assembly Biosciences Reports Third Quarter 2025 Financial Results and Recent Updates
Assembly Biosciences Presents Positive Phase 1b Data for Next-Generation Capsid Assembly Modulator ABI-4334 at AASLD The Liver Meeting®